🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jayhyun Seo

Rush University Medical Center

ORCID: 0000-0002-1599-113X

Also affiliated with Harvard University, Massachusetts General Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study”.

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: A multi-institutional cohort study

Journal of the American Academy of Dermatology(2023)10.1016/j.jaad.2022.12.048
N/A
0DataRank · unranked
80 citations

Kimberly Tang, Guihong Wan, Nga Nguyen, Chenyue Lu, Pearl Ugwu‐Dike +20 more

Influence of melanoma type on incidence and downstream implications of cutaneous immune-related adverse events in the setting of immune checkpoint inhibitor therapy

Journal of the American Academy of Dermatology(2023)10.1016/j.jaad.2023.02.014
N/A
0DataRank · unranked
17 citations

Guihong Wan, Pearl Ugwu‐Dike, Nora A. Alexander, Neel S. Raval, Shijia Zhang +28 more

Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort study

medRxiv(2023)10.1101/2023.01.16.23284635
N/A
0DataRank · unranked
6 citations

Kimberly Tang, Guihong Wan, Nga Nguyen, Chenyue Lu, Pearl Ugwu‐Dike +20 more

Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00278-x
N/A
0DataRank · unranked
95 citations

Wenxin Chen, Sara Khattab, Katie Roster, Nga Nguyen, Boshen Yan +14 more